AAAAAA

   
Results: 1-8 |
Results: 8
THE IMPORTANCE OF LOCO-REGIONAL RADIOTHERAPY WITH CONVENTIONAL OR HIGH-DOSE CHEMOTHERAPY IN THE MANAGEMENT OF BREAST-CANCER WITH GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY NODES
Authors: JABRO G WAZER DE ERBAN J RUTHAZER R
Citation: G. Jabro et al., THE IMPORTANCE OF LOCO-REGIONAL RADIOTHERAPY WITH CONVENTIONAL OR HIGH-DOSE CHEMOTHERAPY IN THE MANAGEMENT OF BREAST-CANCER WITH GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY NODES, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 263-263
COMPARISON OF THE EFFECTS OF SHIGA-LIKE TOXIN-1 ON CYTOKINE-TREATED AND BUTYRATE-TREATED HUMAN UMBILICAL AND SAPHENOUS-VEIN ENDOTHELIAL-CELLS
Authors: KEUSCH GT ACHESON DWK AALDERING L ERBAN J JACEWICZ MS
Citation: Gt. Keusch et al., COMPARISON OF THE EFFECTS OF SHIGA-LIKE TOXIN-1 ON CYTOKINE-TREATED AND BUTYRATE-TREATED HUMAN UMBILICAL AND SAPHENOUS-VEIN ENDOTHELIAL-CELLS, The Journal of infectious diseases, 173(5), 1996, pp. 1164-1170
PROLONGED COURSE OF ADJUSTED-DOSE INTRAVENOUS CYCLOSPORINE AND SHORT-COURSE OF METHOTREXATE TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
Authors: MILLER K SCHENKEIN D ERBAN J HURLEY C BERKMAN E
Citation: K. Miller et al., PROLONGED COURSE OF ADJUSTED-DOSE INTRAVENOUS CYCLOSPORINE AND SHORT-COURSE OF METHOTREXATE TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD), Blood, 86(10), 1995, pp. 1572-1572
TAMOXIFEN-INDUCED STEATOHEPATITIS
Authors: PRATT DS KNOX TA ERBAN J
Citation: Ds. Pratt et al., TAMOXIFEN-INDUCED STEATOHEPATITIS, Annals of internal medicine, 123(3), 1995, pp. 236-236
A RANDOMIZED TRIAL OF FILGRASTIM (G-CSF) PRIMED PERIPHERAL-BLOOD STEM-CELLS (PBSC) VS BONE-MARROW AS A RECONSTITUTION SOURCE FOR HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH LYMPHOMA AND HODGKINS-DISEASE - AN INTERIM CLINICAL AND MOLECULAR ANALYSIS
Authors: SCHENKEIN DP MCCANN L KANTETI R BERKMAN E ERBAN J WECKSTEIN D SWEET M MILLER K
Citation: Dp. Schenkein et al., A RANDOMIZED TRIAL OF FILGRASTIM (G-CSF) PRIMED PERIPHERAL-BLOOD STEM-CELLS (PBSC) VS BONE-MARROW AS A RECONSTITUTION SOURCE FOR HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH LYMPHOMA AND HODGKINS-DISEASE - AN INTERIM CLINICAL AND MOLECULAR ANALYSIS, Blood, 84(10), 1994, pp. 10000204-10000204
SPLENIC IRRADIATION PRIOR TO HIGH-DOSE CHEMOTHERAPY AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: RAVALESE J MADOCJONES H LING M SCHENKEIN D ERBAN J MILLER K
Citation: J. Ravalese et al., SPLENIC IRRADIATION PRIOR TO HIGH-DOSE CHEMOTHERAPY AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, International journal of radiation oncology, biology, physics, 27, 1993, pp. 312-312
ADJUSTED-DOSE CONTINUOUS-INFUSION CYCLOSPORINE-A TO PREVENT GRAFT-VERSUS-HOST DISEASE
Authors: MILLER K SCHENKEIN D COMENZO R ERBAN J FOGAREN T HIRSCH C BERKMAN E RABSON A
Citation: K. Miller et al., ADJUSTED-DOSE CONTINUOUS-INFUSION CYCLOSPORINE-A TO PREVENT GRAFT-VERSUS-HOST DISEASE, Blood, 82(10), 1993, pp. 10000419-10000419
MOUSE NS-1 CELLS SECRETE A POTENT ENDOTHELIAL-CELL RELEASING-FACTOR
Authors: AALDERING L ERBAN J
Citation: L. Aaldering et J. Erban, MOUSE NS-1 CELLS SECRETE A POTENT ENDOTHELIAL-CELL RELEASING-FACTOR, Blood, 82(10), 1993, pp. 10000613-10000613
Risultati: 1-8 |